Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp194 | Pituitary & endocrine Tumours | ECE2017

Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

Casar-Borota Olivera , Botling Johan , Granberg Dan , Wikstrom Johan , Ponten Fredrik , Trouillas Jacqueline

We present a case of a patient with a locally invasive, serotonin- and ACTH-reactive tumour in the sellar region, filling the sphenoid sinus and expanding into the epipharynx. Clinical examination completed by 68-Gallium-DOTA-TOC PET revealed tracer uptake in the sellar tumour as well as in a 7 mm lesion in the pancreatic tail. A differential diagnosis between silent corticotroph adenoma and another primary or secondary neuroendocrine tumour (NET) with ACTH-expression was diff...

ea0099oc5.3 | Oral Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Transcriptomics analysis confirms WHO classification of PitNETs and reveals distinct patterns related to invasiveness

Jotanovic Jelena , Tebani Abdellah , Hekmati Neda , Sivertsson AEsa , Lindskog Cecilia , Uhlen Mathias , Gudjonsson Olafur , Tsatsaris Erika , Eden Engstrom Britt , Wikstrom Johan , Ponten Fredrik , Casar-Borota Olivera

Pituitary neuroendocrine tumors (PitNETs) are typically benign tumors presenting with symptoms related to hormone hypersecretion and/or intracranial mass. Current classification of PitNETs is based on the immunohistochemical expression of adenohypophysial hormones and three main pituitary-specific transcriptions factors PIT1, TPIT and SF1. PitNETs usually remain intrasellar, however, 20-40% of tumors show invasiveness into cavernous sinus and 6–8% infiltrate into the bone...